ACE and COVID-19: Brewster et al. documented that Africans have genetic mutations in the SARS-CoV-2 receptor, angiotensin-converting enzyme-2 (ACE-2) gene, which confers low response to ACE inhibitors and therefore linked to low prevalence of COVID-19 [62].